Cancer survivor since 1992Cancer survivor since 1998Cancer Survivor since 1988Cancer survivor since 1989
Cancer survivor since 1992
Joy Mayuga-Schlossberg: Cancer survivor since 1992

Anti-cancer Modalities at CTCI - Overview

An experimental treatment offered at a clinic in Israel may alleviate multiple sclerosis symptoms, even in patients who have an untreatable form of the disease.
Watch Video here
Pioneering treatment

The International Center for Cell Therapy & Cancer Immunotherapy (CTCI) provides groundbreaking treatments for patients with cancer or non-malignant diseases. Some of the treatments are provided in Israel, and others are provided in other locations, in accordance with local regulations.

The cancer treatments include a broad range of personalized immune therapies, oncolytic virus therapies, and tailored drug regimens with reduced toxicity.

The treatments for non-malignant diseases include regenerative therapies developed by CTCI for neurological diseases and other conditions correctible by bone marrow or adipose-tissue-derived stem cells.

Individualized care

CTCI’s personalized approaches aim to rehabilitate and/or regulate the patient’s immune system, or to introduce donor immune-system cells, to effectively fight disease.

CTCI’s patients benefit from successful state-of-the-art scientific research that is converted quickly into new treatment protocols.

Common diseases treated
Solid tumors, such as:
  - Breast cancer
  - Ovarian cancer
  - Lung cancer
  - Prostate cancer
  - Brain gliomas
  - Ovarian cancer
  - Basal and squamous cell carcinoma
Acute and chronic leukemia
Myelodysplastic syndrome
Non-Hodgkin's lymphoma
Hodgkin's disease
Multiple myeloma
Severe aplastic anemia
Fanconi's anemia
Beta thalassemia major
Sickle cell anemia
Gaucher's disease
Autoimmune diseases
  - Rheumatoid arthritis
  - Systemic lupuserythematosus
Neurological diseases, such as:
  - Multiple sclerosis
  - Amyotrophic lateral sclerosis
  - Parkinson's disease
  - Neurodegenerative & demyelinating disorders
  - Spinal injury
  - Autism
  - Neuroinflammatory disorders
Other conditions treatable by cell therapy or immunotherapy
The goal is cure

CTCI’s goal is to cure cancer and autoimmune diseases. Treatment at an early rather than an advanced stage of disease, before tumor bulk is large and malignant cells are resistant to all treatment, or before extensive damage from autoimmune disease processes has occurred, provides a better prospect for the patient.

CTCI also believes that smarter, rather than “stronger” (i.e., more toxic) treatments can help patients with advanced disease as well.

CTCI Tel Aviv Office and Outpatient Clinic

CTCI Tel Aviv Office and Outpatient Clinic

CTCI Clean Room Production Facility

Contact Us | Terms of Use | Privacy Policy